Più Attivi
Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.
Sei già registrato? Accedi
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Mostra di più
Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0301 | 0.0301 | 0.0301 | 0 | 0 | CS |
4 | 0 | 0 | 0.0301 | 0.0301 | 0.0301 | 0 | 0 | CS |
12 | -0.1699 | -84.95 | 0.2 | 0.2389 | 0.0301 | 1178247 | 0.14931438 | CS |
26 | -0.1919 | -86.4414414414 | 0.222 | 0.2972 | 0.0301 | 1661338 | 0.17920435 | CS |
52 | -1.1099 | -97.3596491228 | 1.14 | 1.31 | 0.0301 | 1005434 | 0.22380255 | CS |
156 | -3.0699 | -99.0290322581 | 3.1 | 5.75 | 0.0301 | 437019 | 0.70022772 | CS |
260 | -16.7299 | -99.8204057279 | 16.76 | 18.24 | 0.0301 | 395624 | 2.02738419 | CS |
Nessuna Discussione Trovata |
Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni